 |
|
|
|
|
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Gouras G, Lin M, Tampellini D. on NEWS: Barreling Down Amyloid Plaque Distribution, Beker and colleagues contribute to the important question of what circuitry and cell types are... 29 Aug 2012.
|
|
|
 |
|
|
Gouras G, Lin M, Tampellini D. on NEWS: Intracellular Aβ Causes Neurodegeneration in Mice, As highlighted in the news story, Abramowski and colleagues chose a risky approach in generating... 14 Feb 2012.
|
|
|
|
|
|
Capetillo-Zarate E, Gouras G, Lin M, Tampellini D. on PAPER: Winton MJ. et al., 2011, We agree with previous comments that Winton and colleagues provide interesting new evidence of... 13 Jun 2011.
|
|
|
|
|
|
Gouras G, Lin M, Tampellini D. on NEWS: Do Overactive Brain Networks Broadcast Alzheimer’s Pathology?, Both the paper by Bero and colleagues and the Alzforum news story make a tacit assumption... 10 May 2011.
|
|
|
|
|
|
Capetillo-Zarate E, Gouras G, Lin M. on NEWS: Popcorn Plaque? Alzheimer Disease Is Slow, Yet Plaque Growth Is Fast, This landmark study provides many exciting new insights into the development of β amyloid... 5 Mar 2008.
|
|
|
|
|
|
Gouras G, Lin M. on PAPER: Tampellini D. et al., 2007, Reply by Davide Tampellini, Michael Lin, Gunnar Gouras
Regarding the technical... 6 Jun 2007.
|
|
|
|
|
|
Lin M. on NEWS: ABAD, aka ERAB: Mitochondrial Miscreant Returns, In this article, Lustbader and colleagues investigate what happens when Aβ interacts with ABAD... 19 Apr 2004.
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our most recent Webinar: 
